GELS
Gelteq Limited Ordinary SharesNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$10.60M
P/E Ratio
—
EPS
$-0.50
Beta
—
52W High
$2.12
52W Low
$0.39
50-Day MA
$0.59
200-Day MA
$0.92
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. The company is headquartered in Caulfield, Australia.
Fundamentals
| Revenue (TTM) | 413,130 |
| Gross Profit (TTM) | 297,740 |
| EBITDA | $-3.84M |
| Operating Margin | -2969.00% |
| Return on Equity | -43.00% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $1.11 |
| Price-to-Book | 0.97 |
| Price-to-Sales (TTM) | 25.67 |
| EV/Revenue | 115.82 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 59.40% |
| Shares Outstanding | $10.71M |
| Float | $4.68M |
| % Insiders | 47.53% |
| % Institutions | 0.58% |
Historical Volatility
HV 10-Day
65.19%
HV 20-Day
84.79%
HV 30-Day
104.85%
HV 60-Day
98.68%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026